Middle East & Africa Nerve Repair & Regeneration Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Neurostimulation & Neuromodulation Devices {Internal Neurostimulation Devices [Spinal Cord Stimulation, Deep Brain Stimulation,

Middle East & Africa Nerve Repair & Regeneration Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Neurostimulation & Neuromodulation Devices {Internal Neurostimulation Devices [Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, and Gastric Electrical Stimulation] and External Neurostimulation Devices [Transcutaneous Electrical Nerve Stimulation Devices, Transcranial Magnetic Stimulation Devices, Respiratory Electrical Stimulation Devices]} and Biomaterials), and Application (Neurostimulation & Neuromodulation Applications {Internal neurostimulation & neuromodulation, and External neurostimulation & neuromodulation}, and Nerve Repair & Regeneration Applications {Direct Nerve Repair/Neurorrhaphy [Epineural Repair, Perineural Repair, and Group Fascicular Repair], Nerve Grafting [Autografts, Allografts, and Xenografts], and Stem cell therapy})

The nerve repair & regeneration market in the Middle East & Africa is expected to grow from US$ 300.76 million in 2022 to US$ 494.31 million by 2028; it is estimated to grow at a CAGR of 8.6% from 2022 to 2028.

Product Launches and Approvals

Nerve repair and regeneration offers products such as neuromodulators, neurostimulation, and biomaterial devices. These devices are utilized for the treatment of neurodegenerative or traumatic disorders such as Parkinson's disease, Alzheimer's disease, sclerosis, multiple system atrophy, and amyotrophic lateral sclerosis. Therefore, market players are launching various products such as internal neurostimulation devices, external neurostimulation devices, nerve conduits, nerve wraps, nerve connectors, and other biomaterials enhance the treatment output of nerve repair and regeneration. A few of the recent developments related to the nerve repair and regeneration market are In July 2022, Checkpoint Surgical launched the Checkpoint Edge Nerve Cutting Kit, expanding the strength of the intraoperative nerve care portfolio of the company. The Checkpoint Edge Nerve Cutting Kit is the first offering in the planned portfolio of nerve-specific instruments by Checkpoint Surgical, with further expansion planned in the future.

Similarly, In Mar-2022: Integra LifeSciences Holding Corporation launched the NeuraGen 3D Nerve Guide Matrix, which is a resorbable implant for the repair of peripheral nerve discontinuities. NeuraGen 3D is a nerve repair product specifically engineered to develop an optimized environment that enables a greater complete functional recovery following mid-gap nerve repair in comparison to hollow nerve conduits alone. Further, In Aug 2021, Checkpoint Surgical, Inc. launched the NeuroShield Chitosan Nerve Wrap to expand its intraoperative nerve care product line. The NeuroShield Wrap marks is the first product in a planned line of chitosan-based biological implants of the company to support nerve healing. Adding the product, complements the existing product portfolio of Checkpoint Surgical, including the company’s flagship Checkpoint Nerve Stimulator/Locator, the leading nerve stimulation device for intraoperative nerve protection and repair. Thus, the active participation of market players in product innovation and development and increase in approvals of products are likely to fuel the market growth in the coming years.

Market Overview

The Middle East & Africa nerve repair & regeneration market is segmented into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. The growing prevalence of neurological disorders and a surge in research and development activities are driving the growth of the nerve repair & regeneration market. According to WHO, ~80% of strokes are expected to occur in low- and middle-income countries. According to Alzheimer’s disease International, the number of people having Alzheimer’s disease is expected to reach 131.5 million by 2050 in low-and middle-income countries. As per the American Academy of Neurology, in 2022, ~17.6 million (11.7%) DALYs were reported in the region. In the UAE, stroke and dementia are the leading causes of disability-adjusted life years (DALYs) and death. According to WHO, in 2020, in the UAE, ~0.51% of total deaths were due to Parkinson’s disease. The growing geriatric population is significantly increasing the prevalence of Alzheimer’s disease. Thus, the increasing prevalence of neurological diseases among the geriatric population of the UAE is driving the growth of the nerve repair & regeneration market.

Middle East & Africa Nerve Repair & Regeneration Market Revenue and Forecast to 2028 (US$ Million)

Middle East & Africa Nerve Repair & Regeneration Market Segmentation

The Middle East & Africa nerve repair & regeneration market is segmented into product, application, and country.

Based on simulator type, the market is segmented into neurostimulation and neuromodulation devices and biomaterial s. The neurostimulation and neuromodulation devices segment registered the largest market share in 2022.

Based on application, the market is categorized into neurostimulation & neuromodulation applications and nerve repair & regeneration applications. The nerve repair & regeneration applications segment held the largest market share in 2022.

Based on country, the Middle East & Africa nerve repair & regeneration market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of MEA. Further, the Rest of MEA dominated the market in 2022.

Axogen Corporation, Boston Scientific Corporation, Integra LifeSciences, Medtronic, Abbott Laboratories, Stryker Corporation, Neuronetics, LivaNova PLC, Baxter, and Polyganics BV are the leading companies operating in the nerve repair & regeneration market in the Middle East & Africa.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe reefer container for pharmaceutical market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in Europe reefer container for pharmaceutical market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.